{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:43:29Z","timestamp":1790790209685,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s11739-022-03125-3","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T02:02:56Z","timestamp":1668736976000},"page":"585-593","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis"],"prefix":"10.1007","volume":"18","author":[{"given":"Maria Vittoria","family":"Silverii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Argir\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Baldasseroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1140-134X","authenticated-orcid":false,"given":"Mattia","family":"Zampieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Guerrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Bartolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Mazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanza","family":"Burgisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Tomberli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Di Mario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Marchionni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Olivotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Perfetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fattirolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"issue":"38","key":"3125_CR1","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","volume":"36","author":"E Gonz\u00e1lez-L\u00f3pez","year":"2015","unstructured":"Gonz\u00e1lez-L\u00f3pez E, Gallego-Delgado M, Guzzo-Merello G et al (2015) Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J 36(38):2585\u20132594. https:\/\/doi.org\/10.1093\/eurheartj\/ehv338","journal-title":"Eur Heart J"},{"issue":"14","key":"3125_CR2","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/eurheartj\/ehz905","volume":"41","author":"L Chacko","year":"2020","unstructured":"Chacko L, Martone R, Bandera F et al (2020) Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis. Eur Heart J 41(14):1439\u20131447. https:\/\/doi.org\/10.1093\/eurheartj\/ehz905","journal-title":"Eur Heart J"},{"issue":"10","key":"3125_CR3","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","volume":"68","author":"M Grogan","year":"2016","unstructured":"Grogan M, Scott CG, Kyle RA et al (2016) Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system. J Am Coll Cardiol 68(10):1014\u20131020. https:\/\/doi.org\/10.1016\/j.jacc.2016.06.033","journal-title":"J Am Coll Cardiol"},{"issue":"30","key":"3125_CR4","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","volume":"39","author":"JD Gillmore","year":"2018","unstructured":"Gillmore JD, Damy T, Fontana M et al (2018) A new staging system for cardiac transthyretin amyloidosis. Eur Heart J 39(30):2799\u20132806. https:\/\/doi.org\/10.1093\/eurheartj\/ehx589","journal-title":"Eur Heart J"},{"issue":"3","key":"3125_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.cjca.2019.12.020","volume":"36","author":"F Cappelli","year":"2020","unstructured":"Cappelli F, Martone R, Gabriele M et al (2020) Biomarkers and prediction of prognosis in transthyretin-related cardiac amyloidosis: direct comparison of two staging systems. Can J Cardiol 36(3):424\u2013431. https:\/\/doi.org\/10.1016\/j.cjca.2019.12.020","journal-title":"Can J Cardiol"},{"issue":"3","key":"3125_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/13506129.2018.1496077","volume":"25","author":"S Hein","year":"2018","unstructured":"Hein S, Aus Dem Siepen F, Bauer R, Katus HA, Kristen AV (2018) Peak V\u2019O2 is an independent predictor of survival in patients with cardiac amyloidosis. Amyloid 25(3):167\u2013173. https:\/\/doi.org\/10.1080\/13506129.2018.1496077","journal-title":"Amyloid"},{"issue":"2","key":"3125_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/ejhf.2016","volume":"23","author":"M Nicol","year":"2021","unstructured":"Nicol M, Deney A, Lairez O et al (2021) Prognostic value of cardiopulmonary exercise testing in cardiac amyloidosis. Eur J Heart Fail 23(2):231\u2013239. https:\/\/doi.org\/10.1002\/ejhf.2016","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"3125_CR8","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.cardfail.2021.06.022","volume":"27","author":"T Dalia","year":"2021","unstructured":"Dalia T, Acharya P, Chan WC et al (2021) Prognostic role of cardiopulmonary exercise testing in wild-type transthyretin amyloid cardiomyopathy patients treated with tafamidis. J Card Fail 27(11):1285\u20131289. https:\/\/doi.org\/10.1016\/j.cardfail.2021.06.022","journal-title":"J Card Fail"},{"issue":"1","key":"3125_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ejhf.979","volume":"20","author":"U Corr\u00e0","year":"2018","unstructured":"Corr\u00e0 U, Agostoni PG, Anker SD et al (2018) Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the committee on exercise physiology and training of the heart failure association of the European Society of Cardiology: cardiopulmonary exercise testing and prognosis in HF. Eur J Heart Fail 20(1):3\u201315. https:\/\/doi.org\/10.1002\/ejhf.979","journal-title":"Eur J Heart Fail"},{"issue":"24","key":"3125_CR10","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH et al (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133(24):2404\u20132412. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.021612","journal-title":"Circulation"},{"issue":"1","key":"3125_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1-39.e14. https:\/\/doi.org\/10.1016\/j.echo.2014.10.003","journal-title":"J Am Soc Echocardiogr"},{"issue":"4","key":"3125_CR12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/01.CIR.55.4.613","volume":"55","author":"RB Devereux","year":"1977","unstructured":"Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method Circulation 55(4):613\u2013618. https:\/\/doi.org\/10.1161\/01.CIR.55.4.613","journal-title":"Anatomic validation of the method Circulation"},{"issue":"4","key":"3125_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29(4):277\u2013314. https:\/\/doi.org\/10.1016\/j.echo.2016.01.011","journal-title":"J Am Soc Echocardiogr"},{"key":"3125_CR14","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1164\/arrd.1984.129.2P2.S49","volume":"129","author":"JE Hansen","year":"1984","unstructured":"Hansen JE, Sue DY, Wasserman K (1984) Predicted values for clinical exercise testing1\u20133. Am Rev Respir Dis 129:S49\u2013S55. https:\/\/doi.org\/10.1164\/arrd.1984.129.2P2.S49","journal-title":"Am Rev Respir Dis"},{"issue":"18","key":"3125_CR15","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1161\/CIR.0b013e31826fb946","volume":"126","author":"M Guazzi","year":"2012","unstructured":"Guazzi M, Adams V, Conraads V et al (2012) Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation 126(18):2261\u20132274. https:\/\/doi.org\/10.1161\/CIR.0b013e31826fb946","journal-title":"Circulation"},{"issue":"8","key":"3125_CR16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jchf.2016.03.022","volume":"4","author":"R Malhotra","year":"2016","unstructured":"Malhotra R, Bakken K, D\u2019Elia E, Lewis GD (2016) Cardiopulmonary exercise testing in heart failure. JACC Heart Fail 4(8):607\u2013616. https:\/\/doi.org\/10.1016\/j.jchf.2016.03.022","journal-title":"JACC Heart Fail"},{"issue":"5","key":"3125_CR17","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1378\/chest.121.5.1572","volume":"121","author":"U Corr\u00e0","year":"2002","unstructured":"Corr\u00e0 U, Giordano A, Bosimini E et al (2002) Oscillatory ventilation during exercise in patients with chronic heart failure. Chest 121(5):1572\u20131580. https:\/\/doi.org\/10.1378\/chest.121.5.1572","journal-title":"Chest"},{"issue":"2","key":"3125_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1161\/CIR.0b013e3181e52e69","volume":"122","author":"GJ Balady","year":"2010","unstructured":"Balady GJ, Arena R, Sietsema K et al (2010) Clinician\u2019s guide to cardiopulmonary exercise testing in adults: a scientific statement from the american heart association. Circulation 122(2):191\u2013225. https:\/\/doi.org\/10.1161\/CIR.0b013e3181e52e69","journal-title":"Circulation"},{"issue":"2","key":"3125_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1161\/CIRCHEARTFAILURE.109.910455","volume":"4","author":"T Bhuiyan","year":"2011","unstructured":"Bhuiyan T, Helmke S, Patel AR et al (2011) Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to v122i mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS). Circ Heart Fail 4(2):121\u2013128. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.910455","journal-title":"Circ Heart Fail"},{"issue":"2","key":"3125_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1161\/CIRCHEARTFAILURE.108.834168","volume":"2","author":"R Arena","year":"2009","unstructured":"Arena R, Myers J, Abella J et al (2009) Determining the preferred percent-predicted equation for peak oxygen consumption in patients with heart failure. Circ Heart Fail 2(2):113\u2013120. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.108.834168","journal-title":"Circ Heart Fail"},{"issue":"2","key":"3125_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0735-1097(95)00464-5","volume":"27","author":"AM Stelken","year":"1996","unstructured":"Stelken AM, Younis LT, Jennison SH et al (1996) Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol 27(2):345\u2013352. https:\/\/doi.org\/10.1016\/0735-1097(95)00464-5","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"3125_CR22","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0735-1097(97)00533-0","volume":"31","author":"N Osada","year":"1998","unstructured":"Osada N, Chaitman BR, Miller LW et al (1998) Cardiopulmonary exercise testing identifies low risk patients with heart failure and severely impaired exercise capacity considered for heart transplantation. J Am Coll Cardiol 31(3):577\u2013582. https:\/\/doi.org\/10.1016\/S0735-1097(97)00533-0","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"3125_CR23","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.healun.2006.06.008","volume":"25","author":"M Mehra","year":"2006","unstructured":"Mehra M, Kobashigawa J, Starling R et al (2006) Listing criteria for heart transplantation: international society for heart and lung transplantation guidelines for the care of cardiac transplant candidates\u20142006. J Heart Lung Transplant 25(9):1024\u20131042. https:\/\/doi.org\/10.1016\/j.healun.2006.06.008","journal-title":"J Heart Lung Transplant"},{"key":"3125_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ahj.2015.12.020","volume":"J174","author":"A Shafiq","year":"2016","unstructured":"Shafiq A, Brawner CA, Aldred HA et al (2016) Prognostic value of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. The Henry Ford HospITal CardioPulmonary EXercise Testing (FIT-CPX) project. Am Heart J174:167\u2013172. https:\/\/doi.org\/10.1016\/j.ahj.2015.12.020","journal-title":"Am Heart"},{"issue":"4","key":"3125_CR25","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jaccao.2021.06.006","volume":"3","author":"JM Griffin","year":"2021","unstructured":"Griffin JM, Rosenthal JL, Grodin JL, Maurer MS, Grogan M, Cheng RK (2021) ATTR amyloidosis: current and emerging management strategies. JACC CardioOncology 3(4):488\u2013505. https:\/\/doi.org\/10.1016\/j.jaccao.2021.06.006","journal-title":"JACC CardioOncology"},{"issue":"11","key":"3125_CR26","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","volume":"379","author":"MS Maurer","year":"2018","unstructured":"Maurer MS, Schwartz JH, Gundapaneni B et al (2018) Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 379(11):1007\u20131016. https:\/\/doi.org\/10.1056\/NEJMoa1805689","journal-title":"N Engl J Med"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-022-03125-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-022-03125-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-022-03125-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T13:51:32Z","timestamp":1678888292000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-022-03125-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["3125"],"URL":"https:\/\/doi.org\/10.1007\/s11739-022-03125-3","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]},"assertion":[{"value":"7 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare that no relationship with the industry exists for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Relationship with industries"}}]}}